Organogenesis Holding (ORGO) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
November 13, 2024 7:16 AM ESTCantor Fitzgerald analyst Ross Osborn raised the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $3.80 (from $3.50) while maintaining a Overweight rating.
The analyst comments "We reiterate our Overweight and increase our 12-month price target to $3.80 from $3.50 on Organogenesis' ("ORGO") shares following the... More
